Richard Riese
Keine laufenden Positionen mehr
Profil
Richard Riese worked as Head-Translational Clinical Sciences at Alexion Pharmaceuticals, Inc. from 2014 to 2017.
He then worked as Vice President-Clinical Development at Alnylam Pharmaceuticals, Inc. from 2017 to 2019.
After that, he worked as Senior Vice President-Clinical Research at AlloVir, Inc. He also worked as Chief Medical Officer at Synlogic, Inc. from 2019 to 2021.
Dr. Riese completed his undergraduate degree from the University of Wisconsin and his doctorate from The Medical College of Wisconsin, Inc.
Ehemalige bekannte Positionen von Richard Riese
| Unternehmen | Position | Ende |
|---|---|---|
| SYNLOGIC, INC. | Chief Tech/Sci/R&D Officer | 29.07.2021 |
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.08.2019 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.01.2017 |
| ALLOVIR, INC. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Richard Riese
| University of Wisconsin | Undergraduate Degree |
| The Medical College of Wisconsin, Inc. | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| ALLOVIR, INC. | Health Technology |
| SYNLOGIC, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
